Speaking Engagements March 09, 2021 11:00 AM - 12:00 PM

How Will Regulation of Digital Products be Impacted by the New Administration?

With the transition to the Biden-Harris Administration, appointing new leadership within the healthcare focused agencies, and the swearing in of the new Congress, the precision medicine industry can expect new attention to critical policy issues including regulation of diagnostic testing, digital health platforms, and at home testing. Is your regulatory team prepared for these changes?

Goodwin Life Sciences and Healthcare partner Delphine O'Rourke will speak on a panel with Jennifer Leib, Founder, Innovation Policy Solutions, Marissa Cruz, Executive Vice President for Clinical and Regulatory Affairs, Everlywell and Kevin Coker, Co-Founder and CEO of Proxima Clinical Research.